PROGENICS PHARMACEUTICALS INC - FORM 10-K/A - EX-31.5 - EXHIBIT 31.5 12,31,09 - October 18, 2010

Attached files

file filename
10-K/A - PROGENICS FORM 10K/A 12,31,09 #2 - PROGENICS PHARMACEUTICALS INCform10k_a.htm
EX-31.6 - EXHIBIT 31.6 12,31,09 - PROGENICS PHARMACEUTICALS INCex31_6.htm
EX-10.35 - EXHIBIT 10.35 12,31,09 - PROGENICS PHARMACEUTICALS INCex10_35.htm
EX-10.34 - EXHIBIT 10.34 12,31,09 - PROGENICS PHARMACEUTICALS INCex10_34.htm
EX-10.36 - EXHIBIT 10.36 12,31,09 - PROGENICS PHARMACEUTICALS INCex10_36.htm



 
Exhibit 31.5

CERTIFICATION
PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a) UNDER THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Paul J. Maddon, M.D., Ph.D., certify that:

1.
I have reviewed this Amendment No. 2 to the annual report on Form 10-K of Progenics Pharmaceuticals, Inc.; and

2.
Based on my knowledge, this Amendment No. 2 to the report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.


 
/s/ Paul J. Maddon
Date: October 18, 2010
Paul J. Maddon, M.D., Ph.D.
Chief Executive Officer and Chief
Science Officer (Principal Executive Officer)


 


Stock widget

Investing forum

PROGENICS PHARMACEUTICALS INC Reports

Also read